Platelet P2Y12 receptors are involved in the haemostatic effect of notoginsenoside Ft1, a saponin isolated from Panax notoginseng

Saponins isolated from Panax notoginseng (Burk.) F.H. Chen have been shown to relieve thrombogenesis and facilitate haemostasis. However, it is not known which saponin accounts for this haemostatic effect. Hence, in the present study we aimed to identify which saponins contribute to its haemostatic activity and to elucidate the possible underlying mechanisms.

[1]  S. Moro,et al.  Role of the extracellular loops of G protein-coupled receptors in ligand recognition: a molecular modeling study of the human P2Y1 receptor. , 1999, Biochemistry.

[2]  F. Liao,et al.  Inhibition of shear-induced platelet aggregation by Chinese herbal medicines. , 1997, Clinical hemorheology and microcirculation.

[3]  J. Cazenave,et al.  The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation. , 1998, Blood.

[4]  J. Augoustides,et al.  Progress in platelet blockers: the target is the P2Y12 receptor. , 2013, Journal of cardiothoracic and vascular anesthesia.

[5]  G. Chiou,et al.  Cardiovascular pharmacology of Panax notoginseng (Burk) F.H. Chen and Salvia miltiorrhiza. , 1986, The American journal of Chinese medicine.

[6]  B. Tomlinson,et al.  Protective effects of trilinolein extracted from panax notoginseng against cardiovascular disease. , 2002, Acta pharmacologica Sinica.

[7]  C. White,et al.  An Evaluation of the Hemostatic Effect of Externally Applied Notoginseng and Notoginseng Total Saponins , 2000, Journal of clinical pharmacology.

[8]  G Burnstock,et al.  Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.

[9]  S. M. Kamruzzaman,et al.  Ginsenoside‐Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation , 2012, British journal of pharmacology.

[10]  I. von Kügelgen,et al.  Involvement of basic amino acid residues in transmembrane regions 6 and 7 in agonist and antagonist recognition of the human platelet P2Y(12)-receptor. , 2008, Biochemical pharmacology.

[11]  Animal Research: Reporting In Vivo Experiments: The ARRIVE guidelines , 2010, The Journal of physiology.

[12]  K. Clemetson.  Platelets and pathogens , 2010, Cellular and Molecular Life Sciences.

[13]  S. Kunapuli,et al.  Central role of the P2Y12 receptor in platelet activation. , 2004, The Journal of clinical investigation.

[14]  R. Storey,et al.  The central role of the P2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity , 2000, British journal of haematology.

[15]  R. Bartlett,et al.  Developing a Small Animal Model of Extracorporeal Circulation , 2006, ASAIO journal.

[16]  H. J. Park,et al.  Effects of dietary supplementation of lipophilic fraction from Panax ginseng on cGMP and cAMP in rat platelets and on blood coagulation. , 1996, Biological & pharmaceutical bulletin.

[17]  T B Ng,et al.  Pharmacological activity of sanchi ginseng (Panax notoginseng) , 2006, The Journal of pharmacy and pharmacology.

[18]  F. Giordanetto,et al.  Ticagrelor binds to human P2Y12 independently from ADP but antagonizes ADP‐induced receptor signaling and platelet aggregation , 2009, Journal of thrombosis and haemostasis : JTH.

[19]  B. Ashby,et al.  Mutational analysis of residues important for ligand interaction with the human P2Y(12) receptor. , 2010, European journal of pharmacology.

[20]  C. Müller,et al.  Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling. , 2009, Journal of medicinal chemistry.

[21]  R. Cristofaro,et al.  Thrombin domains: structure, function and interaction with platelet receptors. , 2003 .

[22]  S. Mccarthy,et al.  Use of fluo-3 to measure cytosolic Ca2+ in platelets and neutrophils. Loading cells with the dye, calibration of traces, measurements in the presence of plasma, and buffering of cytosolic Ca2+. , 1990, The Biochemical journal.

[23]  H. Cao,et al.  Screening of anti-platelet aggregation agents from Panax notoginseng using human platelet extraction and HPLC-DAD-ESI-MS/MS. , 2008, Journal of separation science.

[24]  Masafumi Ueno,et al.  Role of platelets and antiplatelet therapy in cardiovascular disease. , 2011, Journal of atherosclerosis and thrombosis.

[25]  A. Lau,et al.  Antiplatelet and anticoagulant effects of Panax notoginseng: comparison of raw and steamed Panax notoginseng with Panax ginseng and Panax quinquefolium. , 2009, Journal of ethnopharmacology.

[26]  S. Mundell,et al.  Molecular mechanisms of platelet P2Y(12) receptor regulation. , 2013, Biochemical Society transactions.

[27]  C. Kilkenny,et al.  Guidelines for reporting experiments involving animals: the ARRIVE guidelines , 2010, British journal of pharmacology.

[28]  S. Kunapuli,et al.  The role of ADP receptors in platelet function. , 2006, Frontiers in bioscience : a journal and virtual library.

[29]  Guangji Wang,et al.  Pharmacokinetic and absolute bioavailability study of total panax notoginsenoside, a typical multiple constituent traditional chinese medicine (TCM) in rats. , 2007, Biological & pharmaceutical bulletin.

[30]  P. Xiao,et al.  Effects of Panax notoginseng saponins on platelet aggregation in rats with middle cerebral artery occlusion or in vitro and on lipid fluidity of platelet membrane , 1998 .

[31]  G. Davı̀,et al.  Platelet activation and atherothrombosis. , 2007, The New England journal of medicine.